
Mohamed El-Tanani
University of Bradford, UK
Biography
Deputy Director Cancer Therapeutics at University of Bradford. Professor of Molecular Pathology and Cancer Therapeutics at University of Bradford. Over 20 years’ experience in clinical biochemistry and molecular oncology undertaking the molecular mechanism of malignant transformation, biomarker discovery and small molecule drug discovery and its mechanisms of action. Employed at king Khalid hospital (Saudi Arabia) and Alexandria University hospital as a consultant of Clinical Biochemistry and then moved to full research posts in University of Liverpool and then moved to Queen’s University Belfast as lecturer and senior lecturer. Responsible for the discovery of Ran biomarker, a tumour biomarker gene which Gold test for early detection of cancer metastasis and patient stratify for personalised medicine. Member of different company advisory board including UniDiagnostics Ltd (UK) and European Screening port (Germany). Act as Editor and senior editor for several international high profile journal
Abstract
Abstract : Ran as a novel prognostic biomarker